Circulation

NOVEMBER 11, 2024

This study evaluates the outcomes in patients admitted for HF with and without hyperkalemia.Methods:We used the Nationwide Readmissions Database (NRD) from 2016-2019, extracting adult patients with a primary diagnosis of HF who were admitted between January and November of each year. vs. 2.5%, p < 0.001). 2], p<0.001).Conclusion:Hyperkalemia

Inpatient 40

Inpatient Heart Failure Outcomes Cardiac Arrest 40

DAIC

JANUARY 19, 2024

The BACKBEAT pivotal study will evaluate the efficacy and safety of atrioventricular interval modulation (“AVIM”) therapy (also known as BackBeat CNT), for the treatment of pacemaker-indicated patients with uncontrolled hypertension despite the use of antihypertensive medications. Orchestra BioMed and Medtronic, Inc. Kowal, M.D., and Europe.

Pacemaker 105

Pacemaker Hypertension Blood Pressure Kidney Disease 105

Circulation

NOVEMBER 11, 2024

However, the long-term outcomes in patient with an intermediate stenosis received FFR have not yet been investigated comprehensively.Methods:We retrospective included 558 patients underwent both coronary artery angiography (CAG) and FFR. The nomogram consists of age, smoking, hypertension, diabetes mellitus (DM), hyperuricemia, and FFR≤0.8

Coronary Artery Disease 40

Coronary Artery Disease Stenosis Risk Factors Outcomes 40

Open Heart

JUNE 5, 2024

Background There is increasing awareness that patients without standard modifiable risk factors (SMuRFs; diabetes, hypercholesterolaemia, hypertension and smoking) may represent a unique subset of patients with acute coronary syndrome (ACS). The primary outcome was 30-day mortality.

Cardiogenic Shock 52

Cardiogenic Shock Myocardial Infarction Outcomes Coronary Artery Disease 52

Cardiovascular Diabetology

MAY 2, 2024

Recent studies have shown that diabetes mellitus and impaired lipid metabolism are associated with the severity. Insulin resistance (IR) plays an important role in the pathophysiology of cardiovascular disease.

Cardiovascular Disease 52

Cardiovascular Disease Pulmonary Diabetes Hypertension 52

Frontiers in Cardiovascular Medicine

JANUARY 15, 2024

This systematic review of the literature aims to explore outcomes in the patients treated with conservative management vs. invasive strategy. The overall prevalence of arterial hypertension was 33.2%, hyperlipidemia, 26.9%, smoking, 17.8%, and diabetes, 3.9%. The overall mean age was 49.12 +/− 3.41, and 88% were females.

SCAD 75

SCAD Coronary Artery Bypass Graft Outcomes Myocardial Infarction 75

Stroke Journal

FEBRUARY 1, 2024

Objectives:Mixed location intracerebral hemorrhages/ microbleeds (CMBs) (mixed ICH) is referred to as potential hypertensive arteriolosclerosis/cerebral amyloid angiopathy (CAA) combination, reflecting small vessel disease (SVD) burden. There were no significant differences in hypertension, dyslipidemia, and diabetes.

Outcomes 40

Outcomes Hypertension Diabetes Hemorrhage 40

Open Heart

MAY 23, 2024

Background and aims Pre-eclampsia complicates 3–5% of pregnancies worldwide and is associated with adverse outcomes for the mother and the offspring. Pre-eclampsia and heart failure have common risk factors, including hypertension, obesity and diabetes.

Heart Disease 98

Heart Disease Heart Failure Risk Factors Obesity 98

Circulation

OCTOBER 13, 2023

BACKGROUND:Apparent treatment-resistant hypertension (aTRH) is prevalent and associated with adverse outcomes in heart failure with mildly reduced or preserved ejection fraction. Nonresistant hypertension was defined as BP above threshold but not meeting aTRH criteria. Rates of the primary outcome were 8.7

Preserved Ejection Fraction 40

Preserved Ejection Fraction Heart Failure Hypertension Myocardial Infarction 40

Stroke: Vascular and Interventional Neurology

NOVEMBER 9, 2023

IntroductionThere is a higher prevalence of diabetes mellitus type 2 in Hispanics as compared to other ethnic groups in the United States. Diabetes is a risk factor for acute ischemic stroke and also a poor predictor of outcome for many interventional surgeries. or greater. vs. 20.5%; p = 0.048) and stenting (28.4%

Outcomes 40

Outcomes Angioplasty Atrial Fibrillation Diabetes 40

Cardiometabolic Health Congress

NOVEMBER 14, 2024

With the holiday season approaching and fall in full swing, it’s the perfect time to reaffirm our commitment to delivering excellent care, improving patient outcomes, and making the most of every available resource. 42% of adults are considered obese , increasing their risk of diabetes, hypertension, and cardiovascular issues.

CME 96

CME Obesity Heart Failure Biomarkers 96

Cardiometabolic Health Congress

OCTOBER 30, 2024

November is National Diabetes Month , and with the increasing overlap between type 2 diabetes (T2D) and metabolic dysfunction-associated steatohepatitis (MASH) , it’s critical to focus on integrating liver health into the management of cardiometabolic patients.

Diabetes 93

Diabetes Exercise Obesity BMI 93

Coronary Artery Disease Journal

NOVEMBER 20, 2023

Background: Gender-specific outcomes after percutaneous coronary interventions were studied by a number of research groups with different endpoints and cohorts of different ethnic extractions. Materials and methods: The basis for this post hoc analysis was two large all-comers studies with prospectively enrolled patients from Europe and Asia.

Stents 52

Stents Stent Outcomes Coronary Artery Disease 52

Stroke Journal

FEBRUARY 1, 2024

Background:Obesity has been associated with an increase in the risk of stroke and poor outcomes. Trends, demographics, comorbidities, and outcomes were then compared between the two cohorts.Results:Overall Prevalence of stroke was higher in the MHO-ve cohort (2.4% Stroke, Volume 55, Issue Suppl_1 , Page ATP262-ATP262, February 1, 2024.

Obesity 40

Obesity Hospital Stroke Strokes 40

The British Journal of Cardiology

FEBRUARY 20, 2024

We conducted analysis on the determinants of high-risk coronary calcification, represented by CAC score, among women as a step to improve their outcomes and prognosis. We found that a history of hypertension and diabetes are independent determinants of having a high-risk CAC score.

Blood Pressure 52

Blood Pressure Chest Pain Atherosclerosis Hypertension 52

Stroke: Vascular and Interventional Neurology

FEBRUARY 19, 2024

Patients were dichotomized into those with 90‐day good functional outcome (modified Rankin scale [mRS] score 0–2) and poor functional outcome (mRS score ≥3). Good functional outcome was observed in 44 patients (40%). Patients with mRS score 0–2 were less likely to have hypertension (61.4% P = 0.016), and diabetes (18.2%

Stents 40

Stents Stent Circulation Stroke 40

Cardiology Update

JULY 22, 2024

This multicenter open-label, blinded-outcome, randomized trial ( NCT04030234 ), offers new insights into hypertension management. The primary outcome measured was a composite of myocardial infarction, revascularisation, hospitalisation for heart failure, stroke, or cardiovascular death, assessed over a median follow-up of 3.4

Blood Pressure 52

Blood Pressure Myocardial Infarction Hypertension Diabetes 52

The British Journal of Cardiology

APRIL 16, 2024

As a low-volume PCI centre in the Middle East, we wanted to find out if the outcomes of our PCI procedures are different from those of high-volume PCI centres in the UK and the Western world. Prospectively collected data of all comers for PCI (urgent and elective) were retrospectively analysed. Mean age was 60.9 ± 9.4

Outcomes 52

Outcomes Cardiogenic Shock Angina STEMI 52

Coronary Artery Disease Journal

JANUARY 11, 2024

Previous studies showed considerable risks of outcomes in this group. In this study, we aimed to investigate the long-term outcomes in very young patients with MINOCA. They had significantly lower rates of diabetes and hypertension and higher rates of male gender and smoking compared to the older group.

Myocardial Infarction 40

Myocardial Infarction Outcomes Atrial Fibrillation Risk Factors 40

Cardiometabolic Health Congress

JULY 25, 2024

Practical, Future-Focused Education Cardiorenal and metabolic diseases, fueled by poor lifestyle choices and health conditions, lead to type 2 diabetes, cardiovascular disease, and chronic kidney disease. Michos, MD, MHS, FACC, FAHA, FASE, FASPC ; famed hypertension expert Keith C.

Education 98

Education Innovation Risk Factors Obesity 98

Cardiometabolic Health Congress

OCTOBER 18, 2024

Somers, MD, PhD , a consultant in cardiovascular medicine from the Mayo Clinic, discusses how sleep impacts both cardiovascular and metabolic outcomes. There is a clear relationship between sleep deprivation and the development of conditions like obesity, diabetes, and hypertension. In this week’s CMHC Pulse Blog Post, Virend K.

Blood Pressure 94

Blood Pressure Diabetes Obesity Blog 94

Stroke Journal

FEBRUARY 1, 2024

Background:Tenecteplase (TNK) has been reported to be non-inferior to alteplase from a clinical outcome and safety standpoint according to recent studies. Stroke, Volume 55, Issue Suppl_1 , Page AWP31-AWP31, February 1, 2024. A nonsignificant decrease in the odds of symptomatic intracranial hemorrhage (sICH) was seen with TNK.

Stroke 40

Stroke Strokes Hemorrhage Outcomes 40

European Journal of Heart Failure

DECEMBER 12, 2023

Abstract Objectives This study aimed to assess the impact of anemia and iron deficiency (ID) on clinical outcome in patients with cardiogenic shock (CS) complicating acute myocardial infarction (AMI). Nevertheless, data concerning the impact of anemia and ID on clinical outcome in patients with CS are scarce.

Cardiogenic Shock 40

Cardiogenic Shock Myocardial Infarction Outcomes Catheterization Laboratory 40

Stroke: Vascular and Interventional Neurology

NOVEMBER 9, 2023

1) Nevertheless, published research on endovascular treatment outcomes in this population is scarce. 2, 3) In this study, we compared the clinical outcomes of TL patients with the two etiologies.MethodsA retrospective analysis was performed on a multicenter cohort of patients with TLs who underwent endovascular treatment.

Outcomes 40

Outcomes Atherosclerosis Hemorrhage Strokes 40

Stroke Journal

FEBRUARY 1, 2024

Studies have reported racial disparities in young stroke patients and less desired outcomes of minorities. Socioeconomic status, risk factors, stroke etiology, acute interventions and short-term outcomes were accessed. Compared to White, black and Hispanic had higher rate of Diabetes, Hypertension and prior stroke (p<0.001).

Stroke 40

Stroke Strokes Coronary Artery Disease Risk Factors 40

Cardiometabolic Health Congress

AUGUST 8, 2024

Cardiometabolic risk encompasses a complex spectrum of interrelated conditions, including cardiovascular disease, type 2 diabetes, and metabolic syndrome. This blog post explores the development of such partnerships and their potential to transform healthcare outcomes.

Education 59

Education Kidney Disease Cardiovascular Disease Diabetes 59

Heart BMJ

MAY 10, 2024

1 While much effort has been directed at pharmacological and interventional techniques to improve outcomes for those living with these conditions, less has been directed towards identifying factors associated with increased incident risk of AF and non-AF arrhythmias, and strategies to ameliorate them.

Arrhythmia 40

Arrhythmia Myocardial Infarction Atrial Fibrillation Heart Failure 40

Journal of the American Heart Association

FEBRUARY 14, 2024

One such syndrome that has been associated with poor outcomes is cognitive frailty: the simultaneous presence of cognitive impairment, without evidence of dementia, and physical frailty, which results in decreased cognitive reserve.

Cardiovascular Disease 73

Cardiovascular Disease Dementia Obesity Risk Factors 73

Circulation

NOVEMBER 11, 2024

The primary exposure variable was 5-HTP levels, and the primary outcome was the severity of coronary calcification assessed through fluoroscopy. to 1.63); hypertension 1.57 (0.87 to 1.10); diabetes 1.24 (0.67 High 5-HTP levels were significantly associated with more severe calcification (p = 0.04, OR = 3.3, 95% CI = 2.6

Kidney Disease 40

Kidney Disease Risk Factors Pharmacology Diabetes 40

Circulation

NOVEMBER 11, 2024

This study compares outcomes of these treatments and evaluates the correlation between clinical features and medical history with 30-day outcome.Methods:Patients with VBAS were identified from the 2017-2018 National Inpatient Sample (NIS). Hypertension (HTN, 85.4%) and diabetes (DM, 18.9%) were prevalent. Mean age was 69.45

Stenosis 40

Stenosis Inpatient Stent Stents 40

Open Heart

APRIL 6, 2023

This study examined the association of Life’s Simple 7 (LS7) factors and social determinants of health (SDH) with CVD outcomes in a nationally representative sample of AI/ANs. Coronary heart disease, myocardial infarction and stroke were defined as CVD outcomes. to 1.76) were associated with CVD outcomes.

Myocardial Infarction 40

Myocardial Infarction Hypertension Diabetes Risk Factors 40

Open Heart

MARCH 16, 2023

Our aim is to assess whether preoperative and postoperative serum B-type natriuretic peptides levels (BNP) could be used as a predictor of postoperative complications in hypertensive and diabetic patients post non-cardiac surgery. Design Prospective observational study. Setting Single tertiary-care centre in northern India.

Hypertension 52

Hypertension Diabetes Outcomes 52

Hypertension Journal

OCTOBER 10, 2023

Hypertension, Volume 80, Issue 12 , Page 2572-2580, December 1, 2023. BACKGROUND:The STEP (Strategy of Blood Pressure Intervention in the Elderly Hypertensive Patients) trial demonstrated that intensive systolic blood pressure (SBP) lowering has cardiovascular benefits. years, and 46.5% years, and 46.5%

Blood Pressure 40

Blood Pressure Atrial Fibrillation Hypertension Heart Failure 40

ADN Center of Excellence

SEPTEMBER 2, 2024

Factors such as aging populations, rising rates of obesity, hypertension, and other cardiovascular conditions contribute to this increase. Regular screening, especially in high-risk populations, can lead to earlier intervention and better outcomes. By 2050, the number of individuals affected by AFib is expected to more than double.

AFIB 59

AFIB Atrial Fibrillation Innovation Heart Rhythm 59

DAIC

SEPTEMBER 11, 2024

A-Fib, as the condition is commonly known, has been on the rise for at least the past decade, driven by the aging of the population, along with increasing rates of hypertension, diabetes and obesity. million U.S. adults, according to new estimates from University of California-San Francisco. Earlier projections had estimated that 3.3

Atrial Fibrillation 52

Atrial Fibrillation Quality of Life Myocardial Infarction Kidney Disease 52

DAIC

SEPTEMBER 11, 2024

A-Fib, as the condition is commonly known, has been on the rise for at least the past decade, driven by the aging of the population, along with increasing rates of hypertension, diabetes and obesity. million U.S. adults, according to new estimates from University of California-San Francisco. Earlier projections had estimated that 3.3

Atrial Fibrillation 52

Atrial Fibrillation Quality of Life Myocardial Infarction Kidney Disease 52

Journal of the American Heart Association

DECEMBER 29, 2023

Obesity significantly increases AF risk, both directly and indirectly, through related conditions, like hypertension, diabetes, and heart failure. AF increases the risk of stroke, heart failure, dementia, and hospitalization. However, studies on how obesity affects pharmacologic or interventional AF treatments are limited.

Obesity 45

Obesity Atrial Fibrillation Heart Failure Dementia 45